Our technologies are designed and engineered to comprehensively and efficiently profile the human immune repertoire at the sequence level.
We are actively pursuing a few promising novel antibody therapeutics targeting human diseases with great unmet medical needs.
We strive to promote the broad utilization of our technologies by partnering with academic community and commercial entities in antibody discovery.
Please contact our business development team via email firstname.lastname@example.org or the online form. We promise to return your inquiry within 24 hours.
We welcome any potential collaboration opportunity.